X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Vaccines

期刊標題檢索 VACCINES-BASEL 最新評論: I did not submit the manuscript. Because the comment cannot be submitt... (2024-06-15)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Vaccines]您好,您是該頁面的第 49893 位訪客。

期刊簡介
期刊名稱Vaccines Vaccines
LetPub Score
7.3
51 ratings
Rate

Reputation
8.2

Influence
6.0

Speed
9.6

期刊簡稱VACCINES-BASEL
ISSN2076-393X
h-indexN.A.
CiteScore
CiteScoreSJRSNIPCiteScore Rank
8.901.2010.926
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Pharmacology (medical)
Q127 / 272
Category: Medicine
Subcategory: Infectious Diseases
Q156 / 344
Category: Medicine
Subcategory: Pharmacology
Q151 / 313
Category: Medicine
Subcategory: Drug Discovery
Q128 / 157
Category: Medicine
Subcategory: Immunology
Q268 / 236

自引率 (2023-2024)17.30%自引率趨勢
掲載範囲
Vaccines (ISSN 2076-393X) is an international, peer-reviewed open access journal focused on laboratory and clinical vaccine research, utilization and immunization. Vaccines publishes high quality reviews, regular research papers, communications and case reports. Our aim is to encourage scientists to publish their experimental and theoretical results in open access form in as much detail as possible. The full experimental details must be provided so that the results can be reproduced.
官方網站https://www.mdpi.com/journal/vaccines
在線稿件提交https://login.mdpi.com/login?_target_path=https%3A%2F%2Fsusy.mdpi.com%2Fuser%2Flogin%3FauthAll%3Dtrue
開放訪問Yes
出版商MDPI (Basel, Switzerland)
主題領域Pharmacology, Toxicology and Pharmaceutics
出版國/地區Switzerland
發行頻率
創刊年2013
每年文章數1803每年文章數趨勢
黃金OA百分比99.61%
OA Related Info
APC: Yes( CHF2700; )
APC waiver:Check Notes
Other charges: No
Keywords: immunopathogenesis、vaccines
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
IMMUNOLOGYSCIEQ145/181
MEDICINE, RESEARCH & EXPERIMENTALSCIEQ139/189
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2076-393X%5BISSN%5D
平均審稿時間 *來自出版商的數據: 18.06 Day(s)
來自作者的數據: 11 Weeks
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【Vaccines】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Diabetes Metabolic Syndrome and ObesityH-index: 35

    CiteScore: 5.90
    DRUGS IN R&DH-index: 39

    CiteScore: 5.10
    INDIAN JOURNAL OF PHARMACOLOGYH-index: 0

    CiteScore: 4.00
    Contemporary Clinical Trials CommunicationsH-index: 0

    CiteScore: 2.70
    BULLETIN OF PHARMACEUTICAL SCIENCESH-index: 0

    CiteScore: 0.40
    Journal of Jilin University Medicine EditionH-index: 0

    CiteScore: 0.20
    Antiviral Chemistry and ChemotherapyH-index: 0

    CiteScore: 5.20
    Current Pharmacogenomics and Personalized MedicineH-index: 0

    CiteScore: 0.40
    Advances in PharmacologyH-index: 0

    CiteScore: 9.10
    Chinese Journal of Cancer BiotherapyH-index: 0

    CiteScore: 0.20
    學科內最受檢索的期刊 頁面查看次數
    Contemporary Clinical Trials Communications243018
    Diabetes Metabolic Syndrome and Obesity36150
    DRUGS IN R&D12547
    INDIAN JOURNAL OF PHARMACOLOGY9265
    BULLETIN OF PHARMACEUTICAL SCIENCES8091
    Current Pharmacogenomics and Personalized Medicine3388
    Biomedical and Pharmacology Journal3220
    Advances in Pharmacology3071
    Infectious Disorders - Drug Targets2304
    Anti-Infective Agents2207
  •  

    Vaccines Vaccines
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Vaccines] 的評論撰寫評論
作者: 德云小生


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-15 22:16:12 評論於
I did not submit the manuscript. Because the comment cannot be submitted without filling in the above information, I randomly filled in one with an unknown result already submitted! It's not necessary to spend 20,000 to submit to a Q3 journal from MDPI! The reputation is too bad! To be honest, it is not recommended to submit to Q2, unless you are in a hurry to publish and conclude the article! I receive almost every month invitation to submit manuscripts to several Q2/Q3 journals under their umbrella
(0) 讚! | 德云小生

作者: KK


領域: 生物学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2024-03-12 10:52:24 評論於
Received Date
7 February 2024
Revised Date
6 March 2024
Accepted Date
7 March 2024
Published Date
9 March 2024
(0) 讚! | KK

作者: jivin


領域: 医学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2023-08-09 08:24:47 評論於
MDPI is particularly simple, easy to use, and fast (under normal circumstances). This year, its highest impact factor (IF) is Vaccines, which is suitable for beginners to practice with (under no special requirements).
(0) 讚! | jivin

作者: 橙皮漫步


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-15 19:44:45 評論於
It's already March 15th, but it's still pending review. It's really agonizing.
(0) 讚! | 橙皮漫步

作者: 橙皮漫步


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-15 19:44:03 評論於
2023.3.11 Submission
Pending review
(0) 讚! | 橙皮漫步

作者: DSK


領域:
審稿時間: 0.0 month(s)
結果: 拒稿


撰寫評論

2022-12-19 12:28:06 評論於
The fast reviewing process of this journal was satisfying for me. I have published 2 papers in this journal. The evaluation processes were uncomplicated for both of the documents. The editors are also supportive.
(0) 讚! | DSK

作者: youzi


領域: 生物
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2020-03-08 18:45:02 評論於
There were 4 reviewers in total, and the review was detailed, and the questions were very core. The suggestions were helpful to the article. The result of the first review was returned in about 2 weeks, and the result of the second review was replied in about 4 days. Submission is indeed a learning process! Come on!

(5) 讚! | youzi

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Vaccines] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*